In the course of a screening programfor newantibacterial agents produced by rare actinomycetes, we discovered the novel antibiotics A21459 A and B. These antibiotics have cyclic peptide structures1} which are shown in Fig. 1 . We describe the taxonomy and fermentation of the producer strain, isolation of the antibiotics and their biological activity.
Materials and Methods

Taxonomyof Producing Strain
The enantiomeric form of diaminopimelic acid was determined by paper chromatography of whole-cell hydrolysate2). Whole-cell sugars were determined by gas chromatography3). Fatty acids and menaquinones were analyzed according to Saddler Agar Diffusion Assay Production was monitored with agar diffusion assay using Neisseria caviae ATCC14659 grown overnight at 37°C in Todd Hewitt agar (Difco).
Isolation
Harvested broth was filtered and mycelia were extracted with methanol-acetone 1 : 2 (v/v). The extract was then concentrated to water residue and was extracted at pH 7 with ethyl acetate. A crude preparation ofA21459 complex was obtained upon addition of petroleum ether to the concentrated organic phase. The complex and individual factors were then purified by subsequent rounds of flash chromatography on silica gel eluted with mixtures of ethyl acetate and methanol.
HPLC Analysis
The purification process was monitored by HPLCon a 250 x 4.6mm Bakerbond Octyl (5m) column eluted at 1.8 ml/minute flow rate with a 20 minutes linear gradient from 10% to 50% of phase B. PhaseA and Bwere40mM 05 colony-forming units (CFU) per ml or per spot. C. albicans was incubated at 30°C, all other organisms at 37°C. N. gonorrhoeae, P. acnes, C. difficile, B. fragilis and M. gallisepticum were incubated for 48 hours; all other organisms were incubated for 24 hours. MBCswere determined using a broth macrodilution method (media as above) and inocula of approximately 106 CFU/ml. MBCwas taken as the lowest concentration that killed 99.9% of inoculum in 24 hours. 
Mechanismof Action
Mutation to Resistance
An overnight culture of P. vulgaris ATCC881 was FEB. 1996 diluted to approximately 102 CFU/ml in Oxoid No. 2 Nutrient broth and 0.5 ml aliquots were distributed into 22 tubes. After incubation at 37°C for 18 hours, two tubes were pooled for determination of total cell count and the contents of each of the remaining tubes were plated by agar inclusion onto plates containing 50 fig/ml of A21459. Colonies were counted after 18 hours incubation at 37°C. The rate of mutation to resistance was calculated by the Luria-Delbruck method7).
Results
Taxonomyof the Producing Strain
The strain A2 1459 contained m&w-diaminopimelic acid as the sole peptidoglycan diamino acid. Sugar analysis showed xylose and a complex mixture of ribose, arabinose, mannose, galactose and glucose. Fatty acid profile consisted of iso-and anteiso-brdLnched chain and straight chain fully saturated acids. 1 3-methyltetradecanoic acid, Maximal production was obtained after 72~96 hours of incubation. The strain produced ll.5mg/liter of a complex of A21459 A and B present in equal amounts. Isolation and Physico-chemical Properties A21459 A and B, once isolated, had very low solubility in water and showed no ionizable functions either in water or in non-aqueoussolvents. The antibiotics gave positive colour reaction upon heating with 4-methoxybenzaldehyde-H2SO4-ethanol 1 : 1: 1 (v/v). Table  1 contains their molecular formulas, molecular weights and UV maxima. Structure determination is described in the accompanying paper1}. Biological Activity Because no differences in activity were seen between A21459 A and B, we report the antimicrobial activity of the complex. As shown on Table 2 , A21459 was most active against a Gram-positive anaerobe {Clostridium difficile) and a fastidious Gram-negative organism (Neisseria caviae), with MICs of0.03~0.13 fig/ml, but it was significantly less active against Clostridium perfringens and other fastidious Gram-negative species {Neisseria gonorrhoeae, Haemophilus influenzae), with MICs ranging from 8-64/ig/ml. Amongother Grampositive bacteria, A2 1459 was active against Mycoplasma gallisepticum and had slight activity against Staphylococcus aureus, but was inactive against streptococci, Entervcoccusfaecalis, Bacillus subtilis, Propionibacterium acnes and Mycobacterium tuberculosis. Amongother Gram-negative organisms, Pseudomonasaeruginosa was moderately susceptible, as were various species of Proteus, although other membersof the Enterobacteriaceae were uniformly resistant, with the exception of hyperpermeablemutants. The antibiotic was bacteriostatic, as judged by the fourfold or greater difference in the MICs and MBCsagainst isolates of Ps. aeruginosa and P. vulgaris (Table  2 ). This was confirmed in Ps. aeruginosa with a time-kill experiment (data not shown).
Mechanism of action was determined in a hyperpermeable mutant of Salmonella typhimurium. As shown in Fig. 3 , RNAand DNAsynthesis were unaffected, over the course of the experiment, by 50/ig/ml of A21459, while protein synthesis was immediately and completely blocked upon addition of the antibiotic. Peptidoglycan synthesis was partially inhibited, starting at about 5~10 minutes after antibiotic addition.
Rate of mutation to resistance in P. vulgaris was approximately 1 x 10"8/cell/generation. Four indepen- MBC> 128.
MBC>128
(Performed on a single isolate for which the MIC was 4/^g/ml). 147 dently arising mutants {i.e., from different tubes) were purified and tested for their level of resistance by streaking on agar plates containing different concentrations of A21459. They all grew at 200)ug/ml, which is the solubility limit of the antibiotic. When tested for cross-resistance to other antibiotics, the mutants were all as susceptible as the parental strain to rifampicin, chloramphenicol, tetracyclines, ampicillin and gentamicin, suggesting that resistance was due to a change in the target of the antibiotic, rather than to a change in permeability.
This was confirmed by means of a modified protein synthesis cell-free system9) showing IC50 at 2mg/liter for the parental strain and no inhibition up to 50mg/liter for one of the resistant mutants.
Discussion
A21459 has a rather unusual spectrum of antibacterial activity. The antibiotic is very active against C. difficile and mycoplasma and shows activity specifically against some Gram-negative bacteria. Intrinsic resistance appears due in some cases to lack of permeability (Table  2 ) although mutation to resistance in susceptible species appears to be mediated by the protein synthesis apparatus which is the target of the antibiotic. A21459 A and B have novel structures. They are cyclic peptides constituted of a-amino acids and one thiazolyl amino acid. Biosynthesis of thiazoles is typically from cysteine and carboxylic group of one adjacent amino acid10). The peptidic macrocycle of A21459 appears thus originated from eight a-amino acids. Amongmicrobial products, a peptidic macrocycle formed by eight a-amino acids is reported only for fungisporin11'12^Fungisporin is an antibiotic isolated from spores of several species of Penicillium and Aspergillus and is distinct from A21459 in structure and biological activity.
